Your browser doesn't support javascript.
loading
A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome.
Koo, Ray Mun; Wong, Eric; Davis, Joanne E; Perera, Travis; Lim, Andrew; Koldej, Rachel M; Ritchie, David S.
Afiliação
  • Koo RM; ACRF Translational Research Laboratory, Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Wong E; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.
  • Davis JE; Clinical Haematology, Peter MacCallum Cancer Centre-Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Perera T; ACRF Translational Research Laboratory, Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Lim A; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.
  • Koldej RM; Department of Clinical Haematology, Austin Health, Melbourne, VIC, Australia.
  • Ritchie DS; ACRF Translational Research Laboratory, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Bone Marrow Transplant ; 59(7): 1025-1027, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38538726
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Lenalidomida Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Lenalidomida Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália